Jeanne Carter PhD

Dr Carter currently serves as the Head of the Female Sexual Medicine and Women’s Health Program, Gynecology Service, Department of Surgery. This program provides individual interventions to female cancer patients, women at risk of cancer, and survivors coping with the physical and emotional challenges of cancer treatment. She has a dual appointment in the Department of Surgery, Gynecology Service and Department of Psychiatry as an Attending Psychologist. She had an active role in the cooperative group setting of the Gynecologic Oncology Group (GOG), participating as a member of the GOG Quality of Life and Health Outcomes Research Committee (2004-2013), Cancer Prevention and Control (CPC) Committee (2010-2014), and with the merger of the cooperative groups currently serves on the NRG Oncology Group’s Patient-Centered Outcomes Research (PCOR) committee and NRG Cancer Prevention and Control (CPC) Committee.

Some of her research includes serving as the Quality-of-Life Study Chair on NRG-CC0008 (A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROC]). In addition she served as QOL Study Chair for GOG-0278 (Non-Radical Surgical Therapy for Stage IA1-IB1 (≤2 cm) Cervical Cancer; PI Study Chair, Allen Covens, QOL Study Chair for GOG-244, a clinical trial prospectively investigating the incidence and quality-of-life impact of lower extremity lymphedema in women undergoing radical surgery for gynecologic malignancy, was the recipient of a grant from the Lance Armstrong Foundation to examine the psychosexual impact of impaired fertility in female cancer survivors (Carter J, et al. J Cancer Survivorship 2010 Sep;4(3):236-46.) and the PI on a clinical trial investigating a non-hormonal vaginal moisturizer in postmenopausal cancer survivors experiencing estrogen deprivation symptoms”.

Her academic career has focused on cancer, women’s health, symptom management and treatment effects, PROs (patient reported outcomes), QOL and survivorship as a lecturer, author, clinician and researcher on multiple protocols both as PI and Co-PI.